Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

91.23
+18.9626.23%
Volume:8.02M
Turnover:743.16M
Market Cap:11.50B
PE:-27.27
High:95.88
Open:90.00
Low:88.22
Close:72.27
52wk High:95.88
52wk Low:21.28
Shares:126.04M
Float Shares:119.55M
Volume Ratio:3.70
T/O Rate:6.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3453
EPS(LYR):-3.5551
ROE:-4584.47%
ROA:-19.57%
PB:-37.64
PE(LYR):-25.66

Loading ...

Jun 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Apr 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2025

Major Issues Report

Form 8-K - Current report